Prostate Cancer - Results from #27820

Significance of prostate adenocarcinoma perineural invasion on biopsy in patients who are otherwise candidates for active surveillance - Abstract July 7, 2011

Can we stop prostate specific antigen testing 10 years after radical prostatectomy? - Abstract July 7, 2011

Positive surgical margins after robotic assisted radical prostatectomy: A multi-institutional study - Abstract July 7, 2011

Overcoming chemotherapy resistance in prostate cancer - Abstract July 7, 2011

Circulating tumor cells as biomarkers in prostate cancer - Abstract July 7, 2011

Prostate-specific antigen testing in Tyrol, Austria: Prostate cancer mortality reduction was supported by an update with mortality data up to 2008 - Abstract July 7, 2011

Prostate stem cell antigen gene is associated with diffuse and intestinal gastric cancer in Caucasians: Results from the EPIC-EURGAST Study - Abstract July 7, 2011

Editor's Commentary - A pilot study of endorectal magnetic resonance imaging and magnetic resonance spectroscopic imaging changes with dutasteride in patients with low risk prostate cancer July 7, 2011

The potential impact of reproducibility of Gleason grading in men with early stage prostate cancer managed by active surveillance: A multi-institutional study - Abstract July 6, 2011

The deep vein thrombosis caused by lymphocele after endoscopic extraperitoneal radical prostatectomy and pelvic lymph node dissection - Abstract July 6, 2011

Characterizing clinically significant prostate cancer using template prostate mapping biopsy - Abstract July 6, 2011

Tumor focality does not predict biochemical recurrence after radical prostatectomy in men with clinically localized prostate cancer - Abstract July 6, 2011

The influence of information and private versus public provision on preferences for screening for prostate cancer: A willingness-to-pay study - Abstract July 6, 2011

High-dose-rate brachytherapy alone for localized prostate cancer in patients at moderate or high risk of biochemical recurrence - Abstract July 6, 2011

Circulating tumor cells in prostate cancer: A potential surrogate marker of survival - Abstract July 6, 2011

Translating scientific advancement into clinical benefit for castration-resistant prostate cancer patients - Abstract July 6, 2011

Targeting continued androgen receptor signaling in prostate cancer - Abstract July 6, 2011

Immunotherapy for prostate cancer: Recent advances, lessons learned, and areas for further research - Abstract July 6, 2011

Testicular biopsy for early cancer detection - objectives, technique and controversies - Abstract July 6, 2011

Factors associated with vertebral fractures in men treated with androgen deprivation therapy for prostate cancer - Abstract July 5, 2011

Page 1392 of 1450